Wells Fargo’s Cascadian Therapeutics, Inc. CASC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-26,565
| Closed | -$98K | – | 6167 |
|
|
2017
Q4 | $98K | Buy |
26,565
+24,109
| +982% | +$88.9K | ﹤0.01% | 5093 |
|
|
2017
Q3 | $10K | Buy |
2,456
+2,406
| +4,812% | +$9.8K | ﹤0.01% | 5528 |
|
|
2017
Q2 | $0 | Buy |
50
+11
| +28% | – | ﹤0.01% | 6116 |
|
|
2017
Q1 | $0 | Sell |
39
-500
| -93% | – | ﹤0.01% | 6120 |
|
|
2016
Q4 | $2K | Sell |
539
-3
| -0.6% | -$11 | ﹤0.01% | 5714 |
|
|
2016
Q3 | $5K | Sell |
542
-227
| -30% | -$2.09K | ﹤0.01% | 5592 |
|
|
2016
Q2 | $4K | Sell |
769
-7,533
| -91% | -$39.2K | ﹤0.01% | 5565 |
|
|
2016
Q1 | $63K | Buy |
8,302
+914
| +12% | +$6.94K | ﹤0.01% | 4941 |
|
|
2015
Q4 | $98K | Buy |
7,388
+4,179
| +130% | +$55.4K | ﹤0.01% | 4735 |
|
|
2015
Q3 | $53K | Sell |
3,209
-5,872
| -65% | -$97K | ﹤0.01% | 5040 |
|
|
2015
Q2 | $204K | Buy |
9,081
+7,971
| +718% | +$179K | ﹤0.01% | 4460 |
|
|
2015
Q1 | $11K | Sell |
1,110
-2,996
| -73% | -$29.7K | ﹤0.01% | 5398 |
|
|
2014
Q4 | $46K | Buy |
4,106
+81
| +2% | +$907 | ﹤0.01% | 4852 |
|
|
2014
Q3 | $46K | Sell |
4,025
-296
| -7% | -$3.38K | ﹤0.01% | 4834 |
|
|
2014
Q2 | $84K | Sell |
4,321
-3,948
| -48% | -$76.7K | ﹤0.01% | 4643 |
|
|
2014
Q1 | $148K | Buy |
8,269
+8,227
| +19,588% | +$147K | ﹤0.01% | 4398 |
|
|
2013
Q4 | $0 | Sell |
42
-1,859
| -98% | – | ﹤0.01% | 5845 |
|
|
2013
Q3 | $24K | Buy |
1,901
+1,266
| +199% | +$16K | ﹤0.01% | 4833 |
|
|
2013
Q2 | $6K | Buy |
+635
| New | +$6K | ﹤0.01% | 5076 |
|